Your browser doesn't support javascript.
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia.
Konishi, Yoshinobu; Sklavenitis-Pistofidis, Romanos; Yue, Hong; Ferrari, Federico; Redd, Robert A; Lightbody, Elizabeth D; Russo, Massimiliano; Perry, Jacqueline; Horowitz, Erica; Justis, Anna V; Shayegh, Nader A; Savell, Alexandra; Prescott, Julia; Varmeh, Shohreh; Nowak, Radoslaw P; Hamilton, Mark; Auclair, Daniel; Marinac, Catherine R; Trippa, Lorenzo; Fischer, Eric S; Ghobrial, Irene M.
  • Konishi Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Ferrari F; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Redd RA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lightbody ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Russo M; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Justis AV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shayegh NA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Savell A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Prescott J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Varmeh S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Hamilton M; Multiple Myeloma Research Foundation (MMRF), Norwalk, CT, USA.
  • Auclair D; Multiple Myeloma Research Foundation (MMRF), Norwalk, CT, USA.
  • Marinac CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Trippa L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Electronic address: irene_ghobrial@dfci.harvard.edu.
Cancer Cell ; 40(1): 6-8, 2022 01 10.
Article in English | MEDLINE | ID: covidwho-1560948
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / Waldenstrom Macroglobulinemia / SARS-CoV-2 / COVID-19 / BNT162 Vaccine / Ad26COVS1 / Antibodies, Viral / Multiple Myeloma Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2021.12.003

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / Waldenstrom Macroglobulinemia / SARS-CoV-2 / COVID-19 / BNT162 Vaccine / Ad26COVS1 / Antibodies, Viral / Multiple Myeloma Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2021.12.003